Citation
- Authors: Skalka, N., Caspi, M., Caspi, E., Loh, Y. P., Rosin-Arbesfeld, R.
- Year: 2013
- Journal: Oncogene 32 2836-47
- Applications: in vitro / DNA / jetPEI
- Cell types:
- Name: COS-7
Description: African green monkey kidney cells
Known as: COS, COS7 - Name: HEK-293
Description: Human embryonic kidney Fibroblast
Known as: HEK293, 293 - Name: Jurkat
Description: Human acute T cell leukemia line - Name: SW480
Description: Human colon adenocarcinoma cells - Name: U87
Description: Human malignant glioma, glioblastoma cells
Known as: U-87 MG
- Name: COS-7
Abstract
Aberrant activation of the canonical Wnt signal transduction pathway is involved in many diseases including cancer and is especially implicated in the development and progression of colorectal cancer. The key effector protein of the canonical Wnt pathway is beta-catenin, which functions with T-cell factor/lymphoid enhancer factor to activate expression of Wnt target genes. In this study, we used a new functional screen based on cell survival in the presence of cDNAs encoding proteins that activate the Wnt pathway thus identifying novel Wnt signaling components. Here we identify carboxypeptidase E (|CPE) and its splice variant, DeltaN-CPE, as novel regulators of the Wnt pathway. We show that whereas DeltaN-CPE activates the Wnt signal, the full-length CPE (F-CPE) protein is an inhibitor of Wnt/beta-catenin signaling. F-CPE forms a complex with the Wnt3a ligand and the Frizzled receptor. Moreover, F-CPE disrupts disheveled-induced signalosomes that are important for transducing the Wnt signal and reduces beta-catenin protein levels and activity. Taken together, our data indicate that F-CPE and DeltaN-CPE regulate the canonical Wnt signaling pathway negatively and positively, respectively, and demonstrate that this screening approach can be a rapid means for isolation of novel Wnt signaling components.